Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51

• Yimin Wu ,

  Contributed equally to this work with: Yimin Wu, Ruth D. Ellis

  * E-mail: yiwu@niaid.nih.gov (YW); adurbin@jhsph.edu (AD)

  Affiliation Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases, Rockville, Maryland, United States of America

  ⨯
• Ruth D. Ellis ,

  Contributed equally to this work with: Yimin Wu, Ruth D. Ellis

  Affiliation Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases, Rockville, Maryland, United States of America

  ⨯
• Donna Shaffer,

  Affiliation Center for Immunization Research, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America

  ⨯
• Erica Fontes,

  Affiliation Center for Immunization Research, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America

  ⨯
• Elissa M. Malkin,

  Current address: PATH Malaria Vaccine Initiative, Bethesda, Maryland, United States of America

  Affiliation Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases, Rockville, Maryland, United States of America

  ⨯
• Siddhartha Mahanty,

  Current address: Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America

  Affiliation Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases, Rockville, Maryland, United States of America

  ⨯
• Michael P. Fay,

  Affiliation Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America

  ⨯
• David Narum,

  Affiliation Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases, Rockville, Maryland, United States of America

  ⨯
• Kelly Rausch,

  Affiliation Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases, Rockville, Maryland, United States of America

  ⨯
• Aaron P. Miles,

  Current address: Human Hookworm Vaccine Initiative, Department of Microbiology, Immunology, and Tropical Medicine, The George Washington University, Washington D.C., United States of America

  Affiliation Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases, Rockville, Maryland, United States of America

  ⨯
• Joan Aebig,

  Affiliation Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases, Rockville, Maryland, United States of America

  ⨯
• Andrew Orcutt,

  Affiliation Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases, Rockville, Maryland, United States of America

  ⨯
• Olga Muratova,

  Affiliation Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases, Rockville, Maryland, United States of America

  ⨯
• Guanhong Song,

  Affiliation Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases, Rockville, Maryland, United States of America

  ⨯
• Lynn Lambert,

  Affiliation Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases, Rockville, Maryland, United States of America

  ⨯
• Daming Zhu,

  Affiliation Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases, Rockville, Maryland, United States of America

  ⨯
• Kazutoyo Miura,

  Affiliation Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases, Rockville, Maryland, United States of America

  ⨯
• Carole Long,

  Current address: Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, Rockville, Maryland, United States of America

  Affiliation Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases, Rockville, Maryland, United States of America

  ⨯
• Allan Saul,

  Current address: Novartis Vaccines Institute for Global Health, Siena, Italy

  Affiliation Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases, Rockville, Maryland, United States of America

  ⨯
• Louis H. Miller,

  Affiliation Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases, Rockville, Maryland, United States of America

  ⨯
•  [ ... ],
• Anna P. Durbin

  * E-mail: yiwu@niaid.nih.gov (YW); adurbin@jhsph.edu (AD)

  Affiliation Center for Immunization Research, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America

  ⨯
• [ view all ]
• [ view less ]